The European Medicines Agency Ema has recommended to grant an extension of Pfizer-BioNtech’s Covid vaccine indication to include use for children aged 5 to 11 years.
The vaccine is already approved for use in adults and children aged 12 and over.
It reads in a note from the EMA.
The Scientific Technical Commission of the Italian Medicines Agency was convened next week, from 1 to 3 December, with the evaluation of the EMA ruling on anti-Covid vaccination for the pediatric age group 5-11 on the agenda. years.